Breast Cancer Screening Test Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Breast Cancer Screening Test Market?
The market for breast cancer screening tests has seen substantial growth in recent periods. The market value is projected to increase from $2.31 billion in 2024 to $2.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this historical growth include enhanced reimbursement policies, an emphasis on preventive health care, heightened awareness about health, increased research and development efforts, and increased education about the importance of early detection.

In the coming years, the market size for breast cancer screening tests is predicted to witness a significant increase. The market is expected to expand to $3.46 billion by 2029, with a compound annual growth rate (CAGR) of 8.3%. The projected growth during this period can be credited to factors such as a growing number of breast cancer cases, the augmentation of government initiatives, increased spending in the healthcare sector, the proliferation of mobile screening units, and an increasing female population. Key trends expected in the forecast period consist of improvements in imaging technology, the advent of non-invasive screening procedures, advances in genetic and genomic testing, and the introduction of mobile screening services.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24180&type=smp

What Are the Different Breast Cancer Screening Test Market Segments?
The breast cancer screening test market covered in this report is segmented -

1) By Diagnostic Test Type: Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
2) By Risk Level: High-risk Population, Moderate-risk Population, Average-risk Population
3) By End User: Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories

Subsegments
1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
2) By Imaging Test: Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Tomograph Scan, Ultrasound
3) By Genetic Test: Fluorescence In Situ Hybridization, Her Gene Test
4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp

What Are the Primary Drivers Shaping the Breast Cancer Screening Test Market?
The breast cancer screening test market is anticipated to grow due to the escalating prevalence of breast cancer. This type of cancer is characterized by the uncontrolled multiplication of abnormal cells in the breast tissue, leading to the formation of a tumor and the potential spread to other body parts. The surge in breast cancer cases can be attributed to the aging global populace, with advanced age being a significant risk factor, and extended life spans implying more susceptible individuals. These screening tests for breast cancer facilitate early detection of the ailment, thus enhancing the probability of effective treatment and lowering the mortality associated with breast cancer. For example, Breastcancer.org, a nonprofit organization based in the US, projected in March 2025 that around 316,950 women will likely receive a diagnosis for invasive breast cancer in 2025, and about 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS) will be recorded. Furthermore, per the Public Health Agency of Canada, a government agency based in Canada, in December 2024, roughly 28,600 Canadian women are predicted to get diagnosed with breast cancer in 2022, and about 5,500 may succumb to the disease. Hence, the escalating rates of breast cancer incidence are contributing to the expansion of the breast cancer screening test market.

Which Companies Are Leading in the Breast Cancer Screening Test Market?
Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., POC Medical Systems Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., Dxcover Limited

What Are the Major Trends Shaping the Breast Cancer Screening Test Market?
Major firms in the breast cancer screening test market are concentrating on creating novel products such as mobile cancer screening units. These innovations are aimed at enhancing accessibility, ameliorating early detection rates, and increasing the scope of screening in neglected and distant areas. A mobile cancer screening unit is a movable facility featuring diagnostic imaging technologies like mammography, meant to deliver on-site breast cancer screening services in isolated or underserved regions. For example, Granules India Ltd., a pharmaceutical firm from India, inaugurated a Breast Health Express in September 2024 to stimulate breast cancer screening in disadvantaged societies. The unit is furnished with the latest mammography and ultrasound technology, facilitating quality screenings while on the move. This project is geared towards reaching neglected and rural communities that might have limited access to medical facilities, ensuring that females in remote regions have access to life-saving early detection services.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/breast-cancer-screening-test-global-market-report

What Are the Top Revenue-Generating Geographies in the Breast Cancer Screening Test Market?
North America was the largest region in the breast cancer screening test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Breast Cancer Screening Test Market?
2. What is the CAGR expected in the Breast Cancer Screening Test Market?
3. What Are the Key Innovations Transforming the Breast Cancer Screening Test Industry?
4. Which Region Is Leading the Breast Cancer Screening Test Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.